Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

Democrats reveal pricing plan with 250-drug hit list

Democrats reveal pricing plan with 250-drug hit list Germany, Japan and the UK.

ALK-Abello debuts its birch pollen allergy therapy in Germany

ALK-Abello debuts its birch pollen allergy therapy in Germany GlobalData said recently that the overall market for allergic rhinitis immunotherapies will reach $1.14bn by 2028, with the US and Japan contributing the lion’s share of growth based on

Medimmune-born Viela files $150m IPO, eyes first product launch

Medimmune-born Viela files $150m IPO, eyes first product launch Meanwhile, Japan’s Chugai also has positive phase 3 data with its NMOSD candidate satralizumab, an interleukin-6 inhibitor partnered with Roche.

Roche’s flu drug Xofluza scores phase 3 primary endpoint

Roche’s flu drug Xofluza scores phase 3 primary endpoint The drug was discovered and developed by Shionogi, and is already approved in Japan, with Roche holding the marketing rights outside Japan and Taiwan.

AZ builds case for its COPD triple as it chases GSK’s Trelegy

AZ builds case for its COPD triple as it chases GSK’s Trelegy Breztri has its first approval in hand – in Japan – but isn’t due for regulatory decisions in Europe and the US until next year.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics